Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) jumped 28% in the morning session after the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.
Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
AdaptHealth’s shares are very volatile and have had 23 moves greater than 5% over the last year. But moves this big are rare even for AdaptHealth and indicate this news significantly impacted the market’s perception of the business.
AdaptHealth is up 10.4% since the beginning of the year, and at $10.70 per share, it is trading close to its 52-week high of $11.60 from June 2024. Investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at an investment worth $672.42.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.